Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Akorn signs agreement for AK-1015

Aug. 18, 2005

Novel antiglaucoma agents jointly disclosed by Ube and Santen

Aug. 18, 2005

TargeGen selects TG-100801 for clinical development

Aug. 2, 2005

Progress in NicOx ophthalmology collaboration with Pfizer

July 27, 2005

Allergan to evaluate Pharmacopeia compounds in models of ocular disease

July 15, 2005

Senju scientists synthesize novel calpain inhibitors

July 13, 2005

Eyetech selects preclinical candidate in Archemix collaboration

July 7, 2005

New clinical program for intravitreal VEGF Trap for eye diseases

July 7, 2005

Novel compounds for treatment of glaucoma disclosed in patent literature

July 7, 2005

Retisert launched for chronic noninfectious uveitis

July 6, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...